Training Grant in Transfusion Medicine

这是一份续签的NRSA申请(T32 HL69769，“输血医学培训补助金”)，请求 继续支持维持有效和富有成效的输血医学研究培训奖学金 在埃默里大学。输血医学的研究对该领域的未来至关重要，对下游的 世界各地接受输血和细胞治疗的人的安全性。埃默里输血和医疗中心 细胞疗法(CTCT)是最大、最全面的学术输血医学项目之一。 致力于卓越的临床服务，卓越的基础、翻译和临床服务 研究，以及对该领域未来领导者的临床和基于研究的培训。这位T32博士后 科学家培训计划是为埃默里做出贡献并完成其使命的关键要素 CTCT。如果资金续期，这笔赠款将继续为两名博士后CTCT提供工资支持 每年研究实习生，为期5年，参加高度结构化、有指导的培训计划 在输血医学研究方面。我们的目标是满足公认的基本、翻译和 输血医学跨学科研究培训。这种培训对于培养未来的专家是必要的。 在输血、细胞治疗和移植研究方面，以促进进一步的生长和 该专业的研究进展及其对其他研究和临床领域的贡献能力 练习一下。以前确定的计划优势包括：首席调查员/计划主任； 将培训计划作为一个小规模方案组织起来，强调高素质的候选人和研究 项目；拥有强大的科学、资金和培训记录的高级教员的参与；提供 培养研究员和对培训计划进行外部评估的具体机制；以及 以前获得资助的研究员的成功案例。进一步强调该计划致力于提供 在培训博士后研究员方面，教师导师的直接努力仅限于 那些在培训早期职业调查人员方面有大量资金和经过证明的跟踪记录的人。该计划是 最初于2004年提供资金，并于2009年和2014年续签。我们现在正在申请第三次续签，以便开始 2019年。到目前为止，已有14名研究员完成了方案，两名研究员正在接受培训，两名研究员正在接受培训 已确定候选人将在2019年年中/晚些时候开始他们的研究金，如果资金续期的话。我们的T32 院士非常成功，从手稿出版，教员任命，拨款就可以看出这一点 支持和指导委员会审查。方案主任非常感谢所提供的资金 为支持这一重要的培训工作而提供的，以及评审员自愿在 评估这一团契。

This is a renewal NRSA application (T32 HL69769, “Training grant in transfusion medicine”) requesting continued support to maintain an effective and productive Transfusion Medicine Research Training Fellowship at Emory University. Research in transfusion medicine is vital to the future of the field and, downstream, to the safety of recipients of transfusion and cellular therapies worldwide. The Emory Center for Transfusion and Cellular Therapies (CTCT) is one of the largest, most comprehensive academic transfusion medicine programs in the nation and is dedicated to excellence in clinical service, outstanding basic, translational and clinical research, and the clinical and research-based training of future leaders in the field. This T32 Post-Doctoral Scientist Training Program is a critical element in both contributing to, and fulfilling the mission of, the Emory CTCT. If funding is renewed, this grant would continue to provide salary support for two post-doctoral CTCT Research Trainees per year for a 5-year period to participate in a highly structured, mentored training program in transfusion medicine research. We aim to fill the acknowledged need for basic, translational, and interdisciplinary research training in transfusion medicine. Such training is needed to develop future specialists in transfusion, cell therapy and transplantation research in order to contribute to the further growth and research development of the specialty and its ability to contribute to other fields of research and clinical practice. Program strengths previously identified include: the Principal Investigator/Program Director; the organization of the training plan as a small-scale program emphasizing high-quality candidates and research projects; the involvement of senior faculty with strong scientific, funding, and training records; the provision of specific mechanisms for educating fellows and externally evaluating the training program; and the academic successes of previously-supported Fellows. To further underscore the program’s commitment to providing direct personal effort in training post-doctoral research fellows, the faculty mentors have been limited to only those with significant funding and proven track records in training early-career investigators. The Program was initially funded in 2004, and renewed in 2009 and 2014. We are now applying for a third renewal to commence in 2019. To date, 14 Fellows have completed the program, two Fellows are in the middle of training, and two candidates have been identified to begin their fellowships mid/late-2019 should funding be renewed. Our T32 Fellows have been highly successful as evidenced by manuscript publications, faculty appointments, grant support, and Steering Committee review. The Program Director greatly appreciates the funding that has been provided to support this important training effort, and the time and effort volunteered by the reviewers in evaluating this Fellowship.